FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 45 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $920,000 | +9.0% | 229,983 | +32.1% | 0.00% | 0.0% |
| Q1 2019 | $844,000 | -14.2% | 174,050 | +12.9% | 0.00% | -33.3% |
| Q4 2018 | $984,000 | +45.8% | 154,190 | +87.4% | 0.00% | +50.0% |
| Q3 2018 | $675,000 | +16.8% | 82,268 | +48.6% | 0.00% | 0.0% |
| Q2 2018 | $578,000 | +4.3% | 55,348 | +20.7% | 0.00% | +100.0% |
| Q1 2018 | $554,000 | +5.1% | 45,848 | -13.2% | 0.00% | 0.0% |
| Q4 2017 | $527,000 | +15.6% | 52,848 | +28.5% | 0.00% | 0.0% |
| Q3 2017 | $456,000 | – | 41,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |